Biotech · Private company
Encoded Therapeutics
Track this companyFree. Adds Encoded Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ETX101Phase 2 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- No InterventionDravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet SyndromePHASE1_PHASE2 · RECRUITING · started May 14, 2024ClinicalTrials.gov NCT05419492 · fetched Nov 12, 2026
- GABA Biomarkers in Dravet SyndromeRECRUITING · started Sep 8, 2022ClinicalTrials.gov NCT05651204 · fetched Nov 12, 2026
- Natural History Study of Infants and Children With Developmental and Epileptic EncephalopathiesTERMINATED · started Jan 18, 2021ClinicalTrials.gov NCT04537832 · fetched Nov 12, 2026
- Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet SyndromeUNKNOWN · started Nov 2, 2020ClinicalTrials.gov NCT04614506 · fetched Nov 12, 2026